FLT3 AND FLT3-ITD GENE MUTATIONS AND PROGNOSIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

被引：0

作者：

Chen, L. G. ^{[1
]}

Pei, R. Z. ^{[1
]}

Lu, Y. ^{[1
]}

Zhang, P. S. ^{[1
]}

Liu, X. H. ^{[1
]}

Du, X. H. ^{[1
]}

Chen, D. ^{[1
]}

Cao, J. J. ^{[1
]}

Li, S. Y. ^{[1
]}

机构：

[1] Ningbo Univ, Yinzhou Hosp, Med Sch, Dept Hematol, 251 Baizhang East Rd, Ningbo 315040, Peoples R China

来源：

JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS | 2019年 / 33卷 / 06期

关键词：

acute myeloid leukemia; FLT3; FLT3-ITD; gene mutation; C-KIT; INHIBITORS;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1855 / 1861

页数：7

共 11 条

[1] Diagnosis and relapse: cytogenetically normal acute myelogenous leukemia without FLT3-ITD or MLL-PTD [J].

Chien, W. ;

Sun, Q-Y ;

Ding, L-W ;

Mayakonda, A. ;

Takao, S. ;

Liu, L. ;

Lim, Sl ;

Tan, K. T. ;

Garg, M. ;

Varela, A. De Sousa Maria ;

Xiao, J. ;

Jacob, N. ;

Behrens, K. ;

Stocking, C. ;

Lill, M. ;

Madan, V. ;

Hattori, N. ;

Gery, S. ;

Ogawa, S. ;

Wakita, S. ;

Ikezoe, T. ;

Shih, L-Y ;

Alpermann, T. ;

Haferlach, T. ;

Yang, H. ;

Koeffler, H. P. .

LEUKEMIA, 2017, 31 (03) :762-766

[2] IDH1-R132 changes vary according to NPM1 and other mutations status in AML [J].

Falini, Brunangelo ;

Spinelli, Orietta ;

Meggendorfer, Manja ;

Martelli, Maria Paola ;

Bigerna, Barbara ;

Ascani, Stefano ;

Stein, Harald ;

Rambaldi, Alessandro ;

Haferlach, Torsten .

LEUKEMIA, 2019, 33 (04) :1043-1047

[3] The Development of FLT3 Inhibitors in Acute Myeloid Leukemia [J].

Garcia, Jacqueline S. ;

Stone, Richard M. .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (04) :663-+

[4] An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatment [J].

Grafone, Tiziana ;

Palmisano, Michela ;

Nicci, Chiara ;

Storti, Sergio .

ONCOLOGY REVIEWS, 2012, 6 (01) :64-74

[5] Biological and clinical consequences of NPM1 mutations in AML [J].

Heath, E. M. ;

Chan, S. M. ;

Minden, M. D. ;

Murphy, T. ;

Shlush, L. I. ;

Schimmer, A. D. .

LEUKEMIA, 2017, 31 (04) :798-807

[6] Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia [J].

Heydt, Q. ;

Larrue, C. ;

Saland, E. ;

Bertoli, S. ;

Sarry, J-E ;

Besson, A. ;

Manenti, S. ;

Joffre, C. ;

Mas, V. Mansat-De .

ONCOGENE, 2018, 37 (06) :787-797

[7] RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia [J].

Hospital, M-A ;

Jacquel, A. ;

Mazed, F. ;

Saland, E. ;

Larrue, C. ;

Mondesir, J. ;

Birsen, R. ;

Green, A. S. ;

Lambert, M. ;

Sujobert, P. ;

Gautier, E-F ;

Salnot, V. ;

Le Gall, M. ;

Decroocq, J. ;

Poulain, L. ;

Jacque, N. ;

Fontenay, M. ;

Kosmider, O. ;

Recher, C. ;

Auberger, P. ;

Mayeux, P. ;

Bouscary, D. ;

Sarry, J-E ;

Tamburini, J. .

LEUKEMIA, 2018, 32 (03) :597-605

[8] Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JS']JSHCT) [J].

Konuma, Takaaki ;

Mizuno, Shohei ;

Kondo, Tadakazu ;

Yamaguchi, Hiroki ;

Fukuda, Takahiro ;

Uchida, Naoyuki ;

Najima, Yuho ;

Kanamori, Heiwa ;

Ota, Shuichi ;

Nakamae, Hirohisa ;

Nakamae, Mika ;

Mizuno, Ishikazu ;

Sugita, Junichi ;

Onishi, Yasushi ;

Yokota, Akira ;

Takahashi, Satoshi ;

Kanda, Yoshinobu ;

Ichinohe, Tatsuo ;

Atsuta, Yoshiko ;

Yano, Shingo .

ANNALS OF HEMATOLOGY, 2018, 97 (11) :2173-2183

[9] FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions [J].

Larrosa-Garcia, Maria ;

Baer, Maria R. .

MOLECULAR CANCER THERAPEUTICS, 2017, 16 (06) :991-1001

[10] Relapsed NPM1 mutated acute myeloid leukemia with PDGFRA rearrangement [J].

Toruner, Gokce A. ;

Thakral, Beenu .

BLOOD, 2019, 133 (02) :181-181

← 1 2 →